癌症表观遗传学
DNA甲基化
DNA修复
表观遗传学
生物
体育锻炼的表观遗传学
DNA甲基转移酶
DNA去甲基化
甲基转移酶
CpG站点
表观遗传学
DNA错配修复
癌症研究
组蛋白
遗传学
组蛋白甲基化
DNA损伤
组蛋白甲基转移酶
核苷酸切除修复
癌变
基因沉默
发起人
基因表达调控
神经发生的表观遗传调控
O-6-甲基鸟嘌呤-DNA甲基转移酶
表观遗传疗法
RNA导向的DNA甲基化
细胞生物学
癌症
基因
作者
Markus Christmann,Bernd Kaina
标识
DOI:10.1016/j.mrrev.2017.10.001
摘要
DNA repair represents the first barrier against genotoxic stress causing metabolic changes, inflammation and cancer. Besides its role in preventing cancer, DNA repair needs also to be considered during cancer treatment with radiation and DNA damaging drugs as it impacts therapy outcome. The DNA repair capacity is mainly governed by the expression level of repair genes. Alterations in the expression of repair genes can occur due to mutations in their coding or promoter region, changes in the expression of transcription factors activating or repressing these genes, and/or epigenetic factors changing histone modifications and CpG promoter methylation or demethylation levels. In this review we provide an overview on the epigenetic regulation of DNA repair genes. We summarize the mechanisms underlying CpG methylation and demethylation, with de novo methyltransferases and DNA repair involved in gain and loss of CpG methylation, respectively. We discuss the role of components of the DNA damage response, p53, PARP-1 and GADD45a on the regulation of the DNA (cytosine-5)-methyltransferase DNMT1, the key enzyme responsible for gene silencing. We stress the relevance of epigenetic silencing of DNA repair genes for tumor formation and tumor therapy. A paradigmatic example is provided by the DNA repair protein O6-methylguanine-DNA methyltransferase (MGMT), which is silenced in up to 40% of various cancers through CpG promoter methylation. The CpG methylation status of the MGMT promoter strongly correlates with clinical outcome and, therefore, is used as prognostic marker during glioblastoma therapy. Mismatch repair genes are also subject of epigenetic silencing, which was shown to correlate with colorectal cancer formation. For many other repair genes shown to be epigenetically regulated the clinical outcome is not yet clear. We also address the question of whether genotoxic stress itself can lead to epigenetic alterations of genes encoding proteins involved in the defense against genotoxic stress.
科研通智能强力驱动
Strongly Powered by AbleSci AI